[go: up one dir, main page]

NO20060908L - Substituted tazole benzoisothiazole dioxide derivatives, their preparation and use - Google Patents

Substituted tazole benzoisothiazole dioxide derivatives, their preparation and use

Info

Publication number
NO20060908L
NO20060908L NO20060908A NO20060908A NO20060908L NO 20060908 L NO20060908 L NO 20060908L NO 20060908 A NO20060908 A NO 20060908A NO 20060908 A NO20060908 A NO 20060908A NO 20060908 L NO20060908 L NO 20060908L
Authority
NO
Norway
Prior art keywords
tazole
substituted
preparation
dioxide derivatives
benzoisothiazole
Prior art date
Application number
NO20060908A
Other languages
Norwegian (no)
Inventor
Karl-Heinz Baringhaus
Norbert Tennagels
Guenter Mueller
Stefan Petry
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20060908L publication Critical patent/NO20060908L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Det beskrives forbindelser med formel (I) der restene har de angitte betydninger, samt fysiologisk godtakbare salter derav. Forbindelsene egner seg for eksempel som medikamenter for å redusere blodsukkernivåene og for prevensjon og terapi av diabetes.Compounds of formula (I) are described in which the residues have the meanings indicated, as well as physiologically acceptable salts thereof. The compounds are suitable, for example, as medicines for reducing blood sugar levels and for the prevention and therapy of diabetes.

NO20060908A 2003-07-28 2006-02-24 Substituted tazole benzoisothiazole dioxide derivatives, their preparation and use NO20060908L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10334309A DE10334309A1 (en) 2003-07-28 2003-07-28 Substituted thiazole-Benzoisothiazoldioxidderivate, processes for their preparation and their use
PCT/EP2004/007847 WO2005012295A1 (en) 2003-07-28 2004-07-15 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same

Publications (1)

Publication Number Publication Date
NO20060908L true NO20060908L (en) 2006-02-24

Family

ID=34111694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060908A NO20060908L (en) 2003-07-28 2006-02-24 Substituted tazole benzoisothiazole dioxide derivatives, their preparation and use

Country Status (38)

Country Link
EP (1) EP1651644B1 (en)
JP (1) JP2007500145A (en)
KR (1) KR20060052886A (en)
CN (1) CN100413862C (en)
AR (1) AR045113A1 (en)
AT (1) ATE346065T1 (en)
AU (1) AU2004261370B2 (en)
BR (1) BRPI0412997A (en)
CA (1) CA2533673A1 (en)
CR (1) CR8202A (en)
CY (1) CY1105962T1 (en)
DE (2) DE10334309A1 (en)
DK (1) DK1651644T3 (en)
EC (1) ECSP066326A (en)
ES (1) ES2276319T3 (en)
GT (1) GT200400146A (en)
HK (1) HK1091825A1 (en)
IL (1) IL173289A0 (en)
JO (1) JO2449B1 (en)
MA (1) MA27932A1 (en)
MY (1) MY141197A (en)
NO (1) NO20060908L (en)
NZ (1) NZ544975A (en)
OA (1) OA13198A (en)
PA (1) PA8607201A1 (en)
PE (1) PE20050326A1 (en)
PL (1) PL1651644T3 (en)
PT (1) PT1651644E (en)
RS (1) RS20060015A (en)
RU (1) RU2350613C2 (en)
SA (1) SA04250332B1 (en)
SI (1) SI1651644T1 (en)
TN (1) TNSN06030A1 (en)
TW (1) TW200524923A (en)
UA (1) UA83057C2 (en)
UY (1) UY28443A1 (en)
WO (1) WO2005012295A1 (en)
ZA (1) ZA200510378B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026532A1 (en) * 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituted Oxazole Benzoisothiazoldioxidderivate, process for their preparation and their use
AU2007245059B2 (en) 2006-03-31 2011-07-28 Novartis Ag New compounds
MX2009001043A (en) 2006-08-08 2009-02-06 Sanofi Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use.
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
UY31968A (en) 2008-07-09 2010-01-29 Sanofi Aventis NEW HETEROCYCLIC DERIVATIVES, THEIR PROCESSES FOR THEIR PREPARATION, AND THEIR THERAPEUTIC USES
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
CA2771278A1 (en) 2009-08-26 2011-03-03 Sanofi Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012120057A1 (en) 2011-03-08 2012-09-13 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120058A1 (en) 2011-03-08 2012-09-13 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120051A1 (en) 2011-03-08 2012-09-13 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120054A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120055A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2766349B1 (en) 2011-03-08 2016-06-01 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2025017207A1 (en) * 2023-07-20 2025-01-23 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Inhibitors of smndc1 and their therapeutic use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539584A (en) * 1967-11-14 1970-11-10 Colgate Palmolive Co 5-substituted-2,1-benzisothiazolines
JPH04128276A (en) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd Aminobenzosultam derivatives and their uses
CO5190696A1 (en) * 1999-06-16 2002-08-29 Smithkline Beecham Corp ANTAGONISTS OF IL-8 RECEIVERS
DE10038709A1 (en) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituted and unsubstituted benzooxathiazoles and compounds derived from them

Also Published As

Publication number Publication date
TW200524923A (en) 2005-08-01
UY28443A1 (en) 2005-02-28
KR20060052886A (en) 2006-05-19
MA27932A1 (en) 2006-06-01
HK1091825A1 (en) 2007-01-26
CN100413862C (en) 2008-08-27
ECSP066326A (en) 2006-07-28
PE20050326A1 (en) 2005-06-16
MY141197A (en) 2010-03-31
WO2005012295A1 (en) 2005-02-10
EP1651644B1 (en) 2006-11-22
ES2276319T3 (en) 2007-06-16
TNSN06030A1 (en) 2007-10-03
AU2004261370A1 (en) 2005-02-10
AR045113A1 (en) 2005-10-19
DK1651644T3 (en) 2007-03-26
CA2533673A1 (en) 2005-02-10
UA83057C2 (en) 2008-06-10
PT1651644E (en) 2007-01-31
AU2004261370B2 (en) 2009-07-16
PL1651644T3 (en) 2007-03-30
SI1651644T1 (en) 2007-02-28
CN1829715A (en) 2006-09-06
RS20060015A (en) 2007-12-31
PA8607201A1 (en) 2005-03-03
ZA200510378B (en) 2006-11-29
DE502004002117D1 (en) 2007-01-04
IL173289A0 (en) 2006-06-11
NZ544975A (en) 2010-02-26
CY1105962T1 (en) 2011-04-06
DE10334309A1 (en) 2005-03-03
OA13198A (en) 2006-12-13
JO2449B1 (en) 2008-10-09
CR8202A (en) 2008-10-15
GT200400146A (en) 2005-08-12
EP1651644A1 (en) 2006-05-03
SA04250332B1 (en) 2008-02-25
BRPI0412997A (en) 2006-10-03
ATE346065T1 (en) 2006-12-15
RU2006106231A (en) 2006-06-27
JP2007500145A (en) 2007-01-11
RU2350613C2 (en) 2009-03-27

Similar Documents

Publication Publication Date Title
NO20060908L (en) Substituted tazole benzoisothiazole dioxide derivatives, their preparation and use
NO20065926L (en) Substituted Oxazole Benzoisothiazole Dioxide Derivatives and Methods of Preparation and Use thereof
NO20050648L (en) Heterocyclic substituted benzoyl ureas, their preparation method and their use as medicaments
NO20044882L (en) Acyl-4-carboxylphenylurea derivatives, their preparation and use
NO20070176L (en) New fluorine glycoside derivatives of pyrazoles, drugs containing these compounds and their use
NO20091893L (en) New 1,4-benzothiepine-1,1-dioxide derivatives substituted with benzyl groups, processes for the preparation of medicaments containing the compounds and their use.
NO20050828L (en) indole-3-sulfur derivatives
NO20055887L (en) Pyrido'2,1-A-isoquinolide derivatives as DPP-IV inhibitors
NO20051165L (en) Benzothiazole derivatives having -adrenoceptor antagonist activity
NO20082445L (en) Neuropeptide-2 receptor agonists
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
NO20081844L (en) Therapeutic compounds
NO20074703L (en) Antibacterial piperidine derivatives
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
NO20072389L (en) Substituted benzoquinoline derivatives
NO20085064L (en) 4,5-diphenyl-pyrimidinyl-oxy or mercapto-substituted carboxylic acids, processes for their preparation and use thereof as medicaments
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
NO20055680L (en) Hexahydropyridoisoquinolines as DPP-IV inhibitors
EP2397462A3 (en) Compounds, compositions and methods of treatment for heart failure
NO20074872L (en) pyrazoles
NO20082496L (en) pyrazine derivatives
NO20073830L (en) Medications for the treatment or prevention of fibrotic diseases
NO20050134L (en) Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use
NO20063865L (en) Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
NO20055766L (en) Positive modulators of nicotine acetylcholine receptors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application